- Home
- LRMR vs MZYX Comparison
LRMR vs MZYX Comparison
Compare LRMR & MZYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRMR | MZYX |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 375.0M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LRMR | MZYX |
|---|---|---|
| Price | $3.06 | $9.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $14.40 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 41.9K |
| Earning Date | 11-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.72 | $9.90 |
| 52 Week High | $6.42 | $10.10 |
Technical Indicators
Market Signals| Indicator | LRMR | MZYX |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 48.52 |
| Support Level | $3.02 | $9.91 |
| Resistance Level | $3.76 | $10.03 |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 15.36 | 0.00 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MZYX MOZAYYX Acquisition Corp. Class A Ordinary Shares
MOZAYYX Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.